AI and machine learning: FDA spells out specifics from drug discovery to manufacturing
From drug target identification and early discovery work to postmarket surveillance and advanced manufacturing, the FDA on Wednesday outlined its key recommendations on how to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
